QA: DYNAVAX TECHNOLOGIES CORP in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001029142_2021_DYNAVAX_TECHNOLOGIES_CORP.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.09632756437315323, 'aggregate_val': 129860000, 'exp_sum': 118450000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 79256000, 'ResearchAndDevelopmentExpense': 28607000, 'remainder_Expenses': 10587000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001029142, DYNAVAX TECHNOLOGIES CORP

  xvar xval
0 AssetsCurrent 290,015,000
1 IntangibleAssetsNetIncludingGoodwill 2,297,000
2 PropertyPlantAndEquipmentNet 30,567,000
3 remainder_Assets 30,393,000
4 LiabilitiesCurrent 77,411,000
5 LiabilitiesNoncurrent 217,168,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 79,256,000
9 ResearchAndDevelopmentExpense 28,607,000
10 remainder_Expenses 21,997,000
11 remainder_Revenues 54,257,000
12 remainder_NetIncome 363,000
13 remainder_ComprehensiveNetIncome 2,660,000
  yvar yval
0 Assets 353,272,000
1 Liabilities 294,579,000
2 Expenses 129,860,000
3 Revenues 54,257,000
4 StockholdersEquity 58,693,000
5 NetIncome -75,240,000
6 ComprehensiveNetIncome -73,910,000
7 BaseVar 417,495,500
8 EconomicCapitalRatio 0.0835

Edgar->Model Mapping

Feature Distribution

Change over Time